AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Clinical trials for AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA explained in plain language.

Never miss a new study

Get alerted when new AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Sign up with your email to follow new studies for AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Four-Drug attack on tough stomach cancer

Disease control Recruiting now

This study is testing a new combination of four drugs for people with an aggressive type of advanced stomach or gastroesophageal cancer that has continued to grow despite initial treatment with immunotherapy and chemotherapy. The goal is to see if this new drug mix can shrink tum…

Matched conditions: AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Phase: PHASE2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control

Last updated Mar 30, 2026 14:34 UTC

AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA

Get alerted when new AFP GASTRIC OR GASTROESOPHAGEAL JUNCTION ADENOCARCINOMA trials appear

Four-Drug attack on tough stomach cancer